There is also no clear plan to slow the growth of health-care costs. As a sign of their support for the administration’s goals, the pharmaceutical industry and the hospital industry have together promised to reduce costs by a total of about $20 billion a year – a token amount, given government health spending of roughly $1 trillion and total health outlays of more than $2 trillion.